Literature DB >> 12060652

The double-stranded RNA-activated kinase, PKR, can phosphorylate hepatitis D virus small delta antigen at functional serine and threonine residues.

Chi-Wu Chen1, Yeou-Guang Tsay, Hui-Lin Wu, Chi-Hua Lee, Ding-Shinn Chen, Pei-Jer Chen.   

Abstract

Hepatitis D virus (HDV) encodes two proteins, the 24-kDa small delta antigen (S-HDAg) and 27-kDa large delta antigen (L-HDAg) in its single open reading frame. Both of them had been identified as nuclear phosphoproteins. Moreover, the phosphorylated form of S-HDAg was shown to be important for HDV replication. However, the kinase responsible for S-HDAg phosphorylation remains unknown. Therefore, we employed an in-gel kinase assay to search candidate kinases and indeed identified a kinase with a molecular mass of about 68 kDa. Much evidence demonstrated this kinase to be the double-stranded RNA-activated kinase, PKR. The immunoprecipitated endogenous PKR was sufficient to catalyze S-HDAg phosphorylation, and the kinase activity disappeared in the PKR-depleted cell lysate. The S-HDAg and PKR could be co-immunoprecipitated together, and both of them co-located in the nucleolus. The LC/MS/MS analysis revealed that the serine 177, serine 180, and threonine 182 of S-HDAg were phosphorylated by PKR in vitro. This result was consistent with previous phosphoamino acid analysis indicating that serine and threonine were phosphorylation targets in S-HDAg. Furthermore, serine 177 was also shown to be the predominant phosphorylation site for S-HDAg purified the from cell line. In dominant negative PKR-transfected cells, the level of phosphorylated S-HDAg was suppressed, but replication of HDV was enhanced. Other than human immunodeficiency virus type 1 trans-activating protein (Tat), S-HDAg is another viral protein phosphorylated by PKR that may regulates HDV replication and viral response to interferon therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060652     DOI: 10.1074/jbc.M200613200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication.

Authors:  Yi-Jia Li; Michael R Stallcup; Michael M C Lai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 2.  Hepatitis delta virus: A fascinating and neglected pathogen.

Authors:  Celso Cunha; João Paulo Tavanez; Severin Gudima
Journal:  World J Virol       Date:  2015-11-12

Review 3.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

4.  Protein Kinase R Is Constitutively Expressed in the Human Pancreas.

Authors:  Alexander Jonsson; Erik Yngve; Marie Karlsson; Sofie Ingvast; Oskar Skog; Olle Korsgren
Journal:  J Histochem Cytochem       Date:  2018-09-28       Impact factor: 2.479

5.  Recurring features of local tertiary structural elements in RNA molecules exemplified by hepatitis D virus RNA.

Authors:  David A Circle; Alita J Lyons; Olivia D Neel; Hugh D Robertson
Journal:  RNA       Date:  2003-03       Impact factor: 4.942

6.  Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication.

Authors:  Dan Cao; Dirk Haussecker; Yong Huang; Mark A Kay
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

7.  Transcription factor YY1 and its associated acetyltransferases CBP and p300 interact with hepatitis delta antigens and modulate hepatitis delta virus RNA replication.

Authors:  Wen-Hung Huang; Ru-Tsun Mai; Yan-Hwa Wu Lee
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

8.  ERK1/2-mediated phosphorylation of small hepatitis delta antigen at serine 177 enhances hepatitis delta virus antigenomic RNA replication.

Authors:  Yen-Shun Chen; Wen-Hung Huang; Shiao-Ya Hong; Yeou-Guang Tsay; Pei-Jer Chen
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

9.  Resistance of human hepatitis delta virus RNAs to dicer activity.

Authors:  Jinhong Chang; Patrick Provost; John M Taylor
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  The C-terminal sequence of the large hepatitis delta antigen is variable but retains the ability to bind clathrin.

Authors:  Yu-Cheng Wang; Chi-Ruei Huang; Mei Chao; Szecheng J Lo
Journal:  Virol J       Date:  2009-03-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.